Labcorp Holdings Biopharma Laboratory Services — Percent of Revenue Contributed remained flat by 0.0% to 22.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 22.0% to 22.0%.
An increase suggests the segment is growing faster than the rest of the company, while a decrease indicates a shift in revenue mix toward other business areas.
This metric represents the proportion of total corporate revenue generated by the Biopharma Laboratory Services segment....
Commonly reported by diversified healthcare and life sciences companies to show segment concentration.
lh_segment_biopharma_laboratory_services_percent_of_revenue_contributed| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 5.8% | 5.8% | 5.8% | 5.8% | 5.8% | 5.8% | 5.8% | 5.8% | 22% | 22% | 22% | 22% | 22% | 22% | 22% |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +282.6% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +282.6% | +282.6% | +282.6% | +0.0% | +0.0% | +0.0% | +0.0% |